PuSH - Publication Server of Helmholtz Zentrum München

Meredith, L.W.* ; Hu, K.* ; Cheng, X. ; Howard, C.R.* ; Baumert, T.F.* ; Balfe, P.* ; van de Graaf, K.F.* ; Protzer, U. ; McKeating, J.A.

Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors.

J. Gen. Virol. 97, 121-127 (2016)
Publ. Version/Full Text DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Hepatitis B virus (HBV) is one of the world's major unconquered infections, resulting in progressive liver disease and current treatments rarely cure infection. A major limitation to discovering new therapies is our limited knowledge of HBV entry and dissemination pathways that hinders the development of in vitro culture systems. To address this gap in our understanding we optimised the genesis of infectious lentiviral pseudoparticles (HBVpp). The recent discovery that the bile salt transporter NTCP acts as a receptor for HBV enabled us to assess the receptor dependency of HBVpp infection. HBVpp preferentially infect hepatoma cells expressing NTCP, whereas other non-liver cells engineered to express NTCP do not support infection, suggesting that additional hepatocyte-specific factors are required for HBVpp internalisation. These results highlight the value of the HBVpp system to dissect the pathways of HBV entry and dissemination.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Virus; Glycoproteins; Resistant; Mutants; Assay
ISSN (print) / ISBN 0022-1317
e-ISSN 1465-2099
Quellenangaben Volume: 97, Issue: , Pages: 121-127 Article Number: , Supplement: ,
Publisher Society for General Microbiology
Publishing Place Reading
Non-patent literature Publications
Reviewing status Peer reviewed